Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial

Aug. 26, 2003

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Aug. 26, 2003

Good toxicity profile reported for squalamine in patients with solid tumors

Aug. 26, 2003

Local methotrexate reported to inhibit tumor progression in mice

Aug. 26, 2003

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Aug. 25, 2003

Thalidomide recommended for approval in Australia

Aug. 25, 2003

Phase I bridging study of LEP-ETU commences

Aug. 25, 2003

IND filed for Atrigel formulation of octreotide

Aug. 25, 2003

Antitumor effects described for SU-11654 in spontaneous canine tumors

Aug. 25, 2003

Eisai claims novel proteasome inhibitors with utility as antitumor agents

Aug. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...